Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/NABRIVA-THERAPEUTICS-PLC-37853840/news/Nabriva-Therapeutics-plc-Completes-Patient-Enrollment-in-Phase-1-Trial-of-XENLETA-R-in-Adult-Patien-41293487/?utm_source=whatsapp&utm_medium=social&utm_campaign=share